microRNA information: hsa-miR-345-5p
| Section | ID | link |
|---|---|---|
| Mature name: | hsa-miR-345-5p | miRbase |
| Accession: | MIMAT0000772 | miRbase |
| Precursor name: | hsa-mir-345 | miRbase |
| Precursor accession: | MI0000825 | miRbase |
| Symbol: | MIR345 | HGNC |
| RefSeq ID: | NR_029906 | GenBank |
| Sequence: | GCUGACUCCUAGUCCAGGGCUC |
Reported expression in cancers: hsa-miR-345-5p
| miRNA | cancer | regulation | reporting | PUBMED | method |
|---|---|---|---|---|---|
| hsa-miR-345-5p | colorectal cancer | downregulation | "MicroRNA 345 a methylation sensitive microRNA is i ......" | 21665895 | Microarray |
| hsa-miR-345-5p | lung squamous cell cancer | downregulation | "Prognostic significance of tissue miR 345 downregu ......" | 26885027 | qPCR |
| hsa-miR-345-5p | lymphoma | downregulation | "Clinical and epidemiological data suggest that chr ......" | 22307176 | Reverse transcription PCR; in situ hybridization |
| hsa-miR-345-5p | pancreatic cancer | downregulation | "Previously miR-345 was identified as one of the mo ......" | 26247574 | Reverse transcription PCR |
| hsa-miR-345-5p | prostate cancer | downregulation | "In this study we found that the expression of miR- ......" | 26227059 |
Reported cancer pathway affected by hsa-miR-345-5p
| miRNA | cancer | pathway | reporting | PUBMED | functional study |
|---|---|---|---|---|---|
| hsa-miR-345-5p | colorectal cancer | Apoptosis pathway | "MicroRNA 345 a methylation sensitive microRNA is i ......" | 21665895 | Western blot; Luciferase |
| hsa-miR-345-5p | pancreatic cancer | Apoptosis pathway | "MicroRNA 345 induces apoptosis in pancreatic cance ......" | 26247574 | Luciferase |
Reported cancer prognosis affected by hsa-miR-345-5p
| miRNA | cancer | prognosis | reporting | PUBMED | functional study |
|---|---|---|---|---|---|
| hsa-miR-345-5p | breast cancer | drug resistance | "The most significantly dysregulated miRNAs were mi ......" | 20099276 | |
| hsa-miR-345-5p | colorectal cancer | metastasis | "MicroRNA 345 a methylation sensitive microRNA is i ......" | 21665895 | Western blot; Luciferase |
| hsa-miR-345-5p | colorectal cancer | progression; poor survival; drug resistance | "miR 345 in metastatic colorectal cancer: a non inv ......" | 24940606 | |
| hsa-miR-345-5p | endometrial cancer | tumorigenesis | "Hypermethylation of miR-345 and miR-132 associated ......" | 25767621 | |
| hsa-miR-345-5p | lung squamous cell cancer | staging; metastasis; poor survival; progression; worse prognosis | "Prognostic significance of tissue miR 345 downregu ......" | 26885027 | |
| hsa-miR-345-5p | pancreatic cancer | progression; drug resistance | "MicroRNA 345 induces apoptosis in pancreatic cance ......" | 26247574 | Luciferase |
| hsa-miR-345-5p | pancreatic cancer | staging | "In addition from 10 to 50 weeks of age stage-speci ......" | 26516699 | |
| hsa-miR-345-5p | prostate cancer | staging | "miR 19 miR 345 miR 519c 5p serum levels predict ad ......" | 24893170 |
Reported gene related to hsa-miR-345-5p
| miRNA | cancer | gene | reporting | PUBMED |
|---|---|---|---|---|
| hsa-miR-345-5p | breast cancer | ABCC3 | "Furthermore we demonstrated that miR-345 and miR-7 ......" | 20099276 |
| hsa-miR-345-5p | pancreatic cancer | BCL2 | "BCL2 was characterised as a novel target of miR-34 ......" | 26247574 |
| hsa-miR-345-5p | pancreatic cancer | CYCS | "Forced expression of miR-345 results in reduced gr ......" | 26247574 |
| hsa-miR-345-5p | colorectal cancer | KRAS | "miR 345 in metastatic colorectal cancer: a non inv ......" | 24940606 |
| hsa-miR-345-5p | pancreatic cancer | PARP1 | "Forced expression of miR-345 results in reduced gr ......" | 26247574 |
| hsa-miR-345-5p | prostate cancer | SMAD1 | "MiR 345 suppresses proliferation migration and inv ......" | 26227059 |
Expression profile in cancer corhorts:
Putative target regulations
| miRNA | Gene | Cancer | Interaction | Correlation beta |
|---|---|---|---|---|
hsa-miR-345-5p | CDKN1A | 10 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; LUSC; PRAD; THCA; UCEC | miRNAWalker2 validate; miRTarBase; MirTarget | TCGA BLCA -0.215; TCGA BRCA -0.08; TCGA CESC -0.227; TCGA ESCA -0.244; TCGA HNSC -0.223; TCGA KIRC -0.197; TCGA LUSC -0.154; TCGA PRAD -0.113; TCGA THCA -0.233; TCGA UCEC -0.094 |
hsa-miR-345-5p | NTRK3 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; LUAD; LUSC; PRAD; SARC; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.598; TCGA BRCA -0.303; TCGA CESC -0.381; TCGA COAD -0.679; TCGA ESCA -0.713; TCGA LUAD -0.354; TCGA LUSC -0.594; TCGA PRAD -0.23; TCGA SARC -0.347; TCGA THCA -0.222; TCGA STAD -0.498; TCGA UCEC -0.485 |
hsa-miR-345-5p | SPARC | 10 cancers: BLCA; BRCA; CESC; COAD; KIRC; LIHC; LUSC; PAAD; THCA; UCEC | MirTarget | TCGA BLCA -0.285; TCGA BRCA -0.102; TCGA CESC -0.206; TCGA COAD -0.43; TCGA KIRC -0.237; TCGA LIHC -0.183; TCGA LUSC -0.286; TCGA PAAD -0.234; TCGA THCA -0.137; TCGA UCEC -0.178 |
hsa-miR-345-5p | KCNA5 | 9 cancers: BLCA; BRCA; COAD; ESCA; LIHC; LUAD; LUSC; STAD; UCEC | MirTarget | TCGA BLCA -0.499; TCGA BRCA -0.277; TCGA COAD -0.364; TCGA ESCA -0.661; TCGA LIHC -0.206; TCGA LUAD -0.308; TCGA LUSC -0.596; TCGA STAD -0.629; TCGA UCEC -0.311 |
hsa-miR-345-5p | HABP4 | 9 cancers: BLCA; BRCA; ESCA; LIHC; LUSC; PAAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.148; TCGA BRCA -0.109; TCGA ESCA -0.141; TCGA LIHC -0.122; TCGA LUSC -0.157; TCGA PAAD -0.142; TCGA SARC -0.1; TCGA STAD -0.162; TCGA UCEC -0.155 |
hsa-miR-345-5p | CRTAM | 11 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; SARC; THCA; UCEC | MirTarget | TCGA BLCA -0.225; TCGA CESC -0.445; TCGA COAD -0.433; TCGA ESCA -0.329; TCGA HNSC -0.204; TCGA KIRC -0.373; TCGA LUAD -0.216; TCGA LUSC -0.592; TCGA SARC -0.201; TCGA THCA -0.484; TCGA UCEC -0.133 |
hsa-miR-345-5p | MMP16 | 12 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; LIHC; LUSC; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.293; TCGA BRCA -0.143; TCGA COAD -0.495; TCGA ESCA -0.251; TCGA HNSC -0.188; TCGA KIRC -0.294; TCGA LIHC -0.175; TCGA LUSC -0.197; TCGA PRAD -0.156; TCGA THCA -0.887; TCGA STAD -0.326; TCGA UCEC -0.261 |
hsa-miR-345-5p | FAT3 | 10 cancers: BLCA; BRCA; COAD; ESCA; LUAD; LUSC; PRAD; SARC; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.228; TCGA BRCA -0.185; TCGA COAD -0.503; TCGA ESCA -0.524; TCGA LUAD -0.186; TCGA LUSC -0.389; TCGA PRAD -0.382; TCGA SARC -0.463; TCGA STAD -0.738; TCGA UCEC -0.238 |
hsa-miR-345-5p | ARHGEF37 | 9 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LUSC; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.253; TCGA BRCA -0.117; TCGA CESC -0.222; TCGA ESCA -0.369; TCGA HNSC -0.308; TCGA LUSC -0.149; TCGA SARC -0.386; TCGA STAD -0.211; TCGA UCEC -0.128 |
hsa-miR-345-5p | HSPA12A | 12 cancers: BLCA; BRCA; ESCA; HNSC; KIRP; LIHC; LUAD; LUSC; PAAD; PRAD; STAD; UCEC | MirTarget | TCGA BLCA -0.332; TCGA BRCA -0.119; TCGA ESCA -0.247; TCGA HNSC -0.222; TCGA KIRP -0.283; TCGA LIHC -0.215; TCGA LUAD -0.167; TCGA LUSC -0.297; TCGA PAAD -0.469; TCGA PRAD -0.079; TCGA STAD -0.294; TCGA UCEC -0.191 |
hsa-miR-345-5p | ARHGAP6 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LIHC; LUAD; LUSC; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.365; TCGA BRCA -0.186; TCGA CESC -0.164; TCGA COAD -0.245; TCGA ESCA -0.54; TCGA HNSC -0.157; TCGA LIHC -0.197; TCGA LUAD -0.24; TCGA LUSC -0.593; TCGA SARC -0.239; TCGA STAD -0.337; TCGA UCEC -0.562 |
hsa-miR-345-5p | SLC16A7 | 12 cancers: BLCA; CESC; COAD; ESCA; HNSC; LIHC; LUAD; LUSC; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.291; TCGA CESC -0.295; TCGA COAD -0.567; TCGA ESCA -0.43; TCGA HNSC -0.363; TCGA LIHC -0.188; TCGA LUAD -0.237; TCGA LUSC -0.142; TCGA PRAD -0.151; TCGA SARC -0.24; TCGA STAD -0.28; TCGA UCEC -0.39 |
hsa-miR-345-5p | ADARB1 | 11 cancers: BLCA; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; PAAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.288; TCGA COAD -0.128; TCGA ESCA -0.313; TCGA HNSC -0.138; TCGA KIRC -0.087; TCGA LUAD -0.169; TCGA LUSC -0.464; TCGA PAAD -0.15; TCGA THCA -0.117; TCGA STAD -0.258; TCGA UCEC -0.166 |
hsa-miR-345-5p | SSBP2 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; KIRP; LIHC; LUAD; OV; PRAD; SARC; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.16; TCGA BRCA -0.069; TCGA CESC -0.228; TCGA COAD -0.375; TCGA ESCA -0.239; TCGA KIRC -0.1; TCGA KIRP -0.181; TCGA LIHC -0.171; TCGA LUAD -0.107; TCGA OV -0.124; TCGA PRAD -0.06; TCGA SARC -0.172; TCGA STAD -0.355; TCGA UCEC -0.211 |
hsa-miR-345-5p | PCDH10 | 11 cancers: BLCA; BRCA; ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.397; TCGA BRCA -0.137; TCGA ESCA -0.663; TCGA HNSC -0.265; TCGA LUAD -0.169; TCGA LUSC -0.254; TCGA PAAD -0.552; TCGA PRAD -0.28; TCGA THCA -0.151; TCGA STAD -1.011; TCGA UCEC -0.259 |
hsa-miR-345-5p | MAP3K14 | 12 cancers: BLCA; BRCA; CESC; ESCA; KIRC; KIRP; LUAD; LUSC; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.082; TCGA BRCA -0.119; TCGA CESC -0.104; TCGA ESCA -0.132; TCGA KIRC -0.246; TCGA KIRP -0.119; TCGA LUAD -0.071; TCGA LUSC -0.126; TCGA SARC -0.11; TCGA THCA -0.204; TCGA STAD -0.121; TCGA UCEC -0.094 |
hsa-miR-345-5p | KITLG | 10 cancers: BLCA; BRCA; KIRP; LIHC; LUAD; LUSC; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.284; TCGA BRCA -0.111; TCGA KIRP -0.283; TCGA LIHC -0.156; TCGA LUAD -0.139; TCGA LUSC -0.118; TCGA PRAD -0.213; TCGA SARC -0.24; TCGA STAD -0.234; TCGA UCEC -0.293 |
hsa-miR-345-5p | NEK7 | 12 cancers: BLCA; COAD; ESCA; HNSC; KIRP; LUAD; LUSC; OV; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.154; TCGA COAD -0.193; TCGA ESCA -0.203; TCGA HNSC -0.114; TCGA KIRP -0.097; TCGA LUAD -0.13; TCGA LUSC -0.24; TCGA OV -0.079; TCGA PRAD -0.087; TCGA SARC -0.121; TCGA STAD -0.147; TCGA UCEC -0.176 |
hsa-miR-345-5p | DENND5A | 9 cancers: BLCA; COAD; KIRC; LIHC; LUSC; PAAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.14; TCGA COAD -0.22; TCGA KIRC -0.119; TCGA LIHC -0.071; TCGA LUSC -0.117; TCGA PAAD -0.146; TCGA SARC -0.084; TCGA STAD -0.249; TCGA UCEC -0.062 |
hsa-miR-345-5p | RELL1 | 9 cancers: BLCA; ESCA; KIRC; LUAD; LUSC; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.115; TCGA ESCA -0.196; TCGA KIRC -0.126; TCGA LUAD -0.069; TCGA LUSC -0.071; TCGA PRAD -0.071; TCGA SARC -0.128; TCGA STAD -0.059; TCGA UCEC -0.084 |
hsa-miR-345-5p | TMEM204 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; LGG; LIHC; LUAD; LUSC; PAAD; STAD; UCEC | MirTarget | TCGA BLCA -0.223; TCGA BRCA -0.239; TCGA CESC -0.294; TCGA COAD -0.32; TCGA ESCA -0.213; TCGA KIRC -0.212; TCGA LGG -0.066; TCGA LIHC -0.144; TCGA LUAD -0.118; TCGA LUSC -0.445; TCGA PAAD -0.201; TCGA STAD -0.113; TCGA UCEC -0.28 |
hsa-miR-345-5p | RGS1 | 10 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; LUSC; PRAD; THCA; UCEC | MirTarget | TCGA BLCA -0.504; TCGA BRCA -0.085; TCGA CESC -0.327; TCGA COAD -0.342; TCGA HNSC -0.108; TCGA KIRC -0.535; TCGA LUSC -0.34; TCGA PRAD -0.112; TCGA THCA -0.426; TCGA UCEC -0.148 |
hsa-miR-345-5p | SNX29 | 10 cancers: BLCA; COAD; ESCA; HNSC; LIHC; LUAD; LUSC; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.109; TCGA COAD -0.141; TCGA ESCA -0.218; TCGA HNSC -0.142; TCGA LIHC -0.134; TCGA LUAD -0.092; TCGA LUSC -0.146; TCGA SARC -0.056; TCGA STAD -0.154; TCGA UCEC -0.066 |
hsa-miR-345-5p | PLXNA2 | 10 cancers: BLCA; CESC; ESCA; KIRC; LIHC; LUAD; LUSC; PAAD; PRAD; THCA | mirMAP | TCGA BLCA -0.18; TCGA CESC -0.25; TCGA ESCA -0.149; TCGA KIRC -0.176; TCGA LIHC -0.076; TCGA LUAD -0.162; TCGA LUSC -0.191; TCGA PAAD -0.14; TCGA PRAD -0.103; TCGA THCA -0.085 |
hsa-miR-345-5p | RAPGEF3 | 11 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LIHC; LUAD; LUSC; OV; STAD; UCEC | mirMAP | TCGA BLCA -0.277; TCGA BRCA -0.404; TCGA CESC -0.141; TCGA ESCA -0.306; TCGA HNSC -0.244; TCGA LIHC -0.19; TCGA LUAD -0.083; TCGA LUSC -0.423; TCGA OV -0.19; TCGA STAD -0.16; TCGA UCEC -0.16 |
hsa-miR-345-5p | IGSF9B | 11 cancers: BLCA; BRCA; COAD; ESCA; KIRC; KIRP; LUAD; LUSC; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.392; TCGA BRCA -0.337; TCGA COAD -0.185; TCGA ESCA -0.603; TCGA KIRC -0.337; TCGA KIRP -0.233; TCGA LUAD -0.156; TCGA LUSC -0.26; TCGA SARC -0.521; TCGA STAD -0.376; TCGA UCEC -0.46 |
hsa-miR-345-5p | PRX | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; LIHC; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.147; TCGA BRCA -0.353; TCGA CESC -0.098; TCGA COAD -0.116; TCGA ESCA -0.221; TCGA LIHC -0.132; TCGA LUAD -0.234; TCGA LUSC -0.469; TCGA PAAD -0.189; TCGA PRAD -0.064; TCGA THCA -0.059; TCGA STAD -0.169; TCGA UCEC -0.303 |
hsa-miR-345-5p | MDGA1 | 10 cancers: BLCA; BRCA; COAD; LGG; LIHC; LUAD; LUSC; PAAD; STAD; UCEC | mirMAP | TCGA BLCA -0.274; TCGA BRCA -0.206; TCGA COAD -0.337; TCGA LGG -0.087; TCGA LIHC -0.239; TCGA LUAD -0.197; TCGA LUSC -0.177; TCGA PAAD -0.3; TCGA STAD -0.205; TCGA UCEC -0.181 |
hsa-miR-345-5p | IGFBP5 | 9 cancers: BLCA; COAD; ESCA; LIHC; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.455; TCGA COAD -0.509; TCGA ESCA -0.384; TCGA LIHC -0.22; TCGA PRAD -0.117; TCGA SARC -0.25; TCGA THCA -0.551; TCGA STAD -0.225; TCGA UCEC -0.279 |
hsa-miR-345-5p | C1orf21 | 10 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LUAD; PAAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.189; TCGA BRCA -0.169; TCGA CESC -0.292; TCGA ESCA -0.156; TCGA HNSC -0.125; TCGA LUAD -0.109; TCGA PAAD -0.147; TCGA SARC -0.118; TCGA STAD -0.209; TCGA UCEC -0.274 |
hsa-miR-345-5p | CGNL1 | 11 cancers: BLCA; BRCA; COAD; ESCA; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC | mirMAP | TCGA BLCA -0.361; TCGA BRCA -0.183; TCGA COAD -0.213; TCGA ESCA -0.286; TCGA LUAD -0.208; TCGA LUSC -0.524; TCGA OV -0.112; TCGA PAAD -0.235; TCGA PRAD -0.115; TCGA STAD -0.414; TCGA UCEC -0.381 |
hsa-miR-345-5p | PER2 | 10 cancers: BLCA; BRCA; ESCA; KIRC; LGG; OV; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.224; TCGA BRCA -0.121; TCGA ESCA -0.209; TCGA KIRC -0.324; TCGA LGG -0.06; TCGA OV -0.133; TCGA PRAD -0.082; TCGA SARC -0.125; TCGA STAD -0.08; TCGA UCEC -0.111 |
hsa-miR-345-5p | FAIM2 | 11 cancers: BLCA; BRCA; ESCA; HNSC; LGG; LUSC; PAAD; PRAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.58; TCGA BRCA -0.126; TCGA ESCA -0.395; TCGA HNSC -0.222; TCGA LGG -0.095; TCGA LUSC -0.302; TCGA PAAD -0.261; TCGA PRAD -0.242; TCGA THCA -0.562; TCGA STAD -0.179; TCGA UCEC -0.311 |
hsa-miR-345-5p | KIAA1644 | 11 cancers: BLCA; CESC; COAD; ESCA; HNSC; LUSC; PAAD; PRAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.728; TCGA CESC -0.365; TCGA COAD -0.699; TCGA ESCA -0.414; TCGA HNSC -0.294; TCGA LUSC -0.285; TCGA PAAD -0.389; TCGA PRAD -0.28; TCGA THCA -0.298; TCGA STAD -0.506; TCGA UCEC -0.66 |
hsa-miR-345-5p | SCN2B | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.604; TCGA BRCA -0.636; TCGA CESC -0.244; TCGA COAD -0.806; TCGA ESCA -0.744; TCGA HNSC -0.326; TCGA LUAD -0.366; TCGA LUSC -0.525; TCGA PAAD -0.481; TCGA PRAD -0.267; TCGA THCA -0.327; TCGA STAD -0.655; TCGA UCEC -0.484 |
hsa-miR-345-5p | DST | 11 cancers: BLCA; BRCA; CESC; COAD; KIRP; LUAD; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.186; TCGA BRCA -0.134; TCGA CESC -0.189; TCGA COAD -0.181; TCGA KIRP -0.085; TCGA LUAD -0.157; TCGA PRAD -0.112; TCGA SARC -0.212; TCGA THCA -0.478; TCGA STAD -0.283; TCGA UCEC -0.252 |
hsa-miR-345-5p | NFASC | 11 cancers: BLCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.348; TCGA CESC -0.436; TCGA COAD -0.383; TCGA ESCA -0.579; TCGA HNSC -0.253; TCGA LUAD -0.213; TCGA LUSC -0.338; TCGA PRAD -0.107; TCGA SARC -0.528; TCGA STAD -0.523; TCGA UCEC -0.426 |
hsa-miR-345-5p | GRIK3 | 9 cancers: BLCA; BRCA; COAD; ESCA; KIRC; PAAD; PRAD; THCA; STAD | mirMAP | TCGA BLCA -0.417; TCGA BRCA -0.339; TCGA COAD -0.478; TCGA ESCA -0.928; TCGA KIRC -0.957; TCGA PAAD -0.572; TCGA PRAD -0.18; TCGA THCA -0.346; TCGA STAD -0.585 |
hsa-miR-345-5p | TEF | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; LGG; LUAD; OV; PAAD; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.123; TCGA BRCA -0.113; TCGA CESC -0.144; TCGA COAD -0.082; TCGA ESCA -0.152; TCGA LGG -0.08; TCGA LUAD -0.156; TCGA OV -0.121; TCGA PAAD -0.195; TCGA PRAD -0.08; TCGA SARC -0.203; TCGA STAD -0.185; TCGA UCEC -0.273 |
hsa-miR-345-5p | DNAJC18 | 12 cancers: BLCA; BRCA; COAD; ESCA; LIHC; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.146; TCGA BRCA -0.074; TCGA COAD -0.176; TCGA ESCA -0.215; TCGA LIHC -0.114; TCGA LUSC -0.164; TCGA OV -0.115; TCGA PAAD -0.183; TCGA PRAD -0.084; TCGA THCA -0.076; TCGA STAD -0.322; TCGA UCEC -0.167 |
hsa-miR-345-5p | KCNK3 | 13 cancers: BLCA; BRCA; COAD; ESCA; KIRC; KIRP; LGG; LUAD; LUSC; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.47; TCGA BRCA -0.225; TCGA COAD -0.751; TCGA ESCA -0.479; TCGA KIRC -0.514; TCGA KIRP -0.276; TCGA LGG -0.35; TCGA LUAD -0.26; TCGA LUSC -0.599; TCGA PRAD -0.402; TCGA SARC -0.739; TCGA STAD -0.534; TCGA UCEC -0.416 |
hsa-miR-345-5p | SNX33 | 12 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; LUAD; LUSC; OV; SARC; THCA; UCEC | mirMAP | TCGA BLCA -0.069; TCGA BRCA -0.085; TCGA CESC -0.168; TCGA ESCA -0.154; TCGA HNSC -0.17; TCGA KIRC -0.241; TCGA LUAD -0.061; TCGA LUSC -0.096; TCGA OV -0.121; TCGA SARC -0.123; TCGA THCA -0.138; TCGA UCEC -0.086 |
hsa-miR-345-5p | SCN4B | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; LUAD; LUSC; PAAD; PRAD; STAD; UCEC | mirMAP | TCGA BLCA -0.314; TCGA BRCA -0.414; TCGA CESC -0.175; TCGA COAD -0.503; TCGA ESCA -0.515; TCGA KIRC -0.333; TCGA LUAD -0.364; TCGA LUSC -0.364; TCGA PAAD -0.44; TCGA PRAD -0.122; TCGA STAD -0.356; TCGA UCEC -0.488 |
hsa-miR-345-5p | FAM26E | 12 cancers: BLCA; CESC; COAD; ESCA; HNSC; LIHC; LUAD; LUSC; PAAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.308; TCGA CESC -0.158; TCGA COAD -0.512; TCGA ESCA -0.327; TCGA HNSC -0.247; TCGA LIHC -0.163; TCGA LUAD -0.09; TCGA LUSC -0.384; TCGA PAAD -0.22; TCGA SARC -0.191; TCGA STAD -0.165; TCGA UCEC -0.336 |
hsa-miR-345-5p | WSCD1 | 10 cancers: BLCA; BRCA; ESCA; LGG; LUAD; LUSC; PAAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.221; TCGA BRCA -0.267; TCGA ESCA -0.465; TCGA LGG -0.19; TCGA LUAD -0.108; TCGA LUSC -0.377; TCGA PAAD -0.215; TCGA THCA -0.05; TCGA STAD -0.113; TCGA UCEC -0.278 |
hsa-miR-345-5p | SLC6A17 | 9 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRP; PAAD; PRAD; STAD | mirMAP | TCGA BLCA -0.2; TCGA CESC -0.393; TCGA COAD -0.459; TCGA ESCA -0.342; TCGA HNSC -0.266; TCGA KIRP -0.319; TCGA PAAD -0.571; TCGA PRAD -0.187; TCGA STAD -0.161 |
hsa-miR-345-5p | LRP10 | 9 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LUSC; PRAD; SARC; THCA | mirMAP | TCGA BLCA -0.174; TCGA BRCA -0.098; TCGA CESC -0.099; TCGA ESCA -0.191; TCGA HNSC -0.166; TCGA LUSC -0.161; TCGA PRAD -0.077; TCGA SARC -0.126; TCGA THCA -0.135 |
hsa-miR-345-5p | SPN | 12 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; LUAD; LUSC; PRAD; SARC; THCA; UCEC | mirMAP | TCGA BLCA -0.27; TCGA BRCA -0.071; TCGA CESC -0.339; TCGA COAD -0.286; TCGA HNSC -0.176; TCGA KIRC -0.264; TCGA LUAD -0.271; TCGA LUSC -0.661; TCGA PRAD -0.125; TCGA SARC -0.222; TCGA THCA -0.475; TCGA UCEC -0.114 |
hsa-miR-345-5p | MAFK | 11 cancers: BLCA; BRCA; CESC; ESCA; KIRC; KIRP; LUSC; OV; SARC; THCA; UCEC | mirMAP | TCGA BLCA -0.084; TCGA BRCA -0.197; TCGA CESC -0.125; TCGA ESCA -0.125; TCGA KIRC -0.205; TCGA KIRP -0.101; TCGA LUSC -0.193; TCGA OV -0.106; TCGA SARC -0.138; TCGA THCA -0.071; TCGA UCEC -0.131 |
hsa-miR-345-5p | RORA | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; PAAD; STAD; UCEC | miRNATAP | TCGA BLCA -0.172; TCGA BRCA -0.07; TCGA CESC -0.298; TCGA COAD -0.415; TCGA ESCA -0.284; TCGA HNSC -0.147; TCGA KIRC -0.137; TCGA LUAD -0.147; TCGA LUSC -0.121; TCGA PAAD -0.211; TCGA STAD -0.288; TCGA UCEC -0.264 |
hsa-miR-345-5p | KLF9 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.45; TCGA BRCA -0.161; TCGA CESC -0.134; TCGA COAD -0.257; TCGA ESCA -0.495; TCGA HNSC -0.126; TCGA LUAD -0.222; TCGA LUSC -0.422; TCGA PAAD -0.167; TCGA PRAD -0.1; TCGA SARC -0.282; TCGA STAD -0.384; TCGA UCEC -0.387 |
hsa-miR-345-5p | SORBS1 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.679; TCGA BRCA -0.178; TCGA CESC -0.203; TCGA COAD -0.387; TCGA ESCA -0.787; TCGA HNSC -0.187; TCGA KIRC -0.138; TCGA LUAD -0.277; TCGA LUSC -0.501; TCGA PAAD -0.29; TCGA PRAD -0.287; TCGA SARC -0.603; TCGA STAD -0.653; TCGA UCEC -0.546 |
hsa-miR-345-5p | NBL1 | 9 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LIHC; LUSC; THCA; UCEC | miRNATAP | TCGA BLCA -0.296; TCGA BRCA -0.25; TCGA CESC -0.176; TCGA ESCA -0.173; TCGA HNSC -0.12; TCGA LIHC -0.245; TCGA LUSC -0.222; TCGA THCA -0.416; TCGA UCEC -0.323 |
hsa-miR-345-5p | TPCN1 | 10 cancers: BRCA; HNSC; LGG; LIHC; LUAD; LUSC; OV; SARC; STAD; UCEC | MirTarget; mirMAP | TCGA BRCA -0.161; TCGA HNSC -0.078; TCGA LGG -0.051; TCGA LIHC -0.13; TCGA LUAD -0.067; TCGA LUSC -0.226; TCGA OV -0.127; TCGA SARC -0.119; TCGA STAD -0.052; TCGA UCEC -0.122 |
hsa-miR-345-5p | ID4 | 11 cancers: BRCA; COAD; ESCA; LIHC; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BRCA -0.191; TCGA COAD -0.326; TCGA ESCA -0.227; TCGA LIHC -0.228; TCGA LUSC -0.217; TCGA OV -0.175; TCGA PAAD -0.306; TCGA PRAD -0.227; TCGA SARC -0.215; TCGA STAD -0.289; TCGA UCEC -0.232 |
hsa-miR-345-5p | CTTNBP2NL | 10 cancers: CESC; HNSC; LIHC; LUAD; LUSC; OV; PRAD; THCA; STAD; UCEC | MirTarget | TCGA CESC -0.105; TCGA HNSC -0.088; TCGA LIHC -0.111; TCGA LUAD -0.058; TCGA LUSC -0.085; TCGA OV -0.076; TCGA PRAD -0.051; TCGA THCA -0.155; TCGA STAD -0.092; TCGA UCEC -0.095 |
hsa-miR-345-5p | N4BP1 | 9 cancers: CESC; COAD; HNSC; LUAD; LUSC; OV; THCA; STAD; UCEC | mirMAP | TCGA CESC -0.188; TCGA COAD -0.05; TCGA HNSC -0.127; TCGA LUAD -0.118; TCGA LUSC -0.148; TCGA OV -0.06; TCGA THCA -0.053; TCGA STAD -0.054; TCGA UCEC -0.072 |
hsa-miR-345-5p | TRIM13 | 11 cancers: CESC; HNSC; KIRC; LGG; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC | miRNATAP | TCGA CESC -0.06; TCGA HNSC -0.055; TCGA KIRC -0.052; TCGA LGG -0.063; TCGA LUAD -0.07; TCGA LUSC -0.052; TCGA OV -0.112; TCGA PAAD -0.076; TCGA PRAD -0.052; TCGA STAD -0.091; TCGA UCEC -0.097 |
Enriched cancer pathways of putative targets